11-03-2022 Currently, FUSE-AI is preparing the certification of the software Prostate.Carcinoma.ai for MDR IIa and FDA 510k. The contracts have already been signed in July by BSI as the notified body. . NSF / Prosystem is on our side as a supportive consulting company for a fluent certification process. "The experienced consultants of NSF impressed…

11-03-2022 Tailor-made support will be provided along all development phases - from proof of concept to scaling and to a successful internationalization. "We are looking forward to the accelerator program with great ambition because it will be like a booster for the company" says Matthias Steffen, CEO of FUSE-AI. The AI.STARTUP.HUB supports, accelerates and scales…

The higher the quality of the data, the more precise are AI results FUSE-AI's new AI-assisted radiology software Prostate.Carcinoma.ai has the aim to simplify and accelerate the detection of suspicious regions in prostate MRI analysis. In addition, FUSE-AI's AI backbone is applicable to automatic image and data recognition in medicine, pharmaceuticals, and biotechnology. The software…

Svante Paabo, the PhD supervisor of our co-founder Dr. Sabrina Reimers-Kipping receives the Nobel Prize in Physiology / Medicine Sabrina worked in the Pääbo lab at the Max Planck Institute for Evolutionary Anthropology in Leipzig from 2006 - 2011. She did her PhD in biochemistry on physiological differences of the human and ancestral version of…

09-13-2022 Global distribution launched at the G20 Digital Innovation Network The G20 Digital Innovation Network is a high-level forum for sharing knowledge, fostering discussion, and building partnerships between global innovation players. It aims to serve as a bridge for cooperation between different players at the global level.For the last meeting in Bali at the beginning…

07-28-2022 Matthias Steffen and Dr. Andreas Raguse (Radiology Consultant of FUSE-AI) visited the European Congress of Radiology (ECR) in Vienna. On July 15, they jointly received a market overview of software solutions for AI-based image recognition in radiological diagnostics at one of the most significant radiology congress. New and already available business contacts were keenly…

07-28-2022 Despite all oppressive circumstances that are currently making life hard for medical device manufacturers - and which could potentially threaten the existence of some of these companies - we have succeeded: FUSE-AI and their products will be certified by the Notified Body BSI Group! "We are pleased about our new client FUSE-AI GmbH from…

06.07.2022 Viel Zeit und viel Geld – darauf müssen sich Hersteller von Medizinprodukten und In-vitro-Diagnostika einstellen. Das Problem: die geringe Anzahl an Benannten Stellen und sowohl regulatorische als auch finanzielle Herausforderungen besonders für Start-ups und kleine Unternehmen. Juri Rohde besuchte am 1. Juli den 15. Institutstag des Johner Instituts im Bodenseeforum zum Thema: „Die Zukunft der…

06.07.2022 Unternehmen, die im KI-Bereich Health gründen möchten, konnten am 5. Juli 2022 bei der Veranstaltung „AI in Health Heroes“ von der Erfahrung anderer, bereits erfolgreicher KI-Start-ups profitieren. Matthias Steffen verriet, welche Prozesse eine wichtige Rolle spielen und welche Voraussetzungen gegeben sein sollten, damit sich eine neue Idee mit einem neuen Unternehmen erfolgreich auf dem…

06.07.2022 Am 29. Juni 2022 waren die Mitglieder des DiagnostikNet BB zu einem Webinar eingeladen, in dem FUSE-AI über KI-Anwendungen im Gesundheitswesen informierte. Rund 50 Anmeldungen sind dazu eingegangen. Der Verband bündelt seit 2007 in Berlin-Brandenburg die Interessen innovativer mittelständischer Unternehmen und international renommierter Forschungsinstitute aus allen Bereichen der in-vitro Diagnostik. In unserem Impulsvortrag gaben…